French engineer-virologist Thomas Mollet examines cells infected with a Sars-CoV-2 virus at the Biosafety level 3 laboratory in Saint-Herblain, France. Jean-Francois Monier/AFP via Getty Images ...

U.S. policy, China’s strategic rise, blockbuster deals and AI dominated South Korea’s biotechnology industry this year, with U.S. tariffs and the Biosecure Act’s hitch onto 2026 legislation serving as ...

Legend Biotech's share price is little changed despite concerns raised by the FDA in AdCom briefing documents. The increased rate of early deaths in the CARTITUDE-4 trial could reduce the use of ...

The European Commission is concerned that diverging policies in member states could derail the European Union's Strategy for Life Sciences and Biotechnology. The concern is expressed in the Commission ...

LONDON (Reuters) - Biotech stocks advanced in Europe on Monday as the failure of Pfizer Inc's experimental drug torcetrapib highlighted pipeline problems at big pharma firms, which are expected to ...

This week's biotech gathering in San Francisco gives us an opportunity to highlight the advances in science and medicine that have resulted from biotechnological discoveries, and to encourage and ...